ABSTRACT
A cross-disciplinary rapid scoping review was carried out generally following PRIMA-SCR protocol to examine historical racial and caste-based discrimination as structural determinants of health disparities in the 21st century. We selected 48 peer-reviewed full-text articles available from the University of Memphis Libraries database search, focusing on three selected case-study countries-the United States (US), Canada and Nepal. Authors read each article, extracted highlights and tabulated the thematic contents on structural health disparities attributed to racism or casteism. Results linked the historical racism/casteism to health disparities occurring in Blacks and African Americans, Native Americans and other ethnic groups in the US, in Indigenous peoples and other visible minorities in Canada, and in Dalits of Nepal, a population racialized by caste, grounded on at least four foundational theories explaining structural determinants of health disparities. The evidence from the literature indicates that genetic variations and biological differences (e.g., disease occurrence) occur within and between races/castes for various reasons (e.g., random gene mutations, geographic isolation, and endogamy). However, historical races/castes as socio-cultural constructs have no inherently exclusive basis of biological differences. Disregarding genetic discrimination based on pseudo-scientific theories, genetic testing is a valuable scientific means to achieve better health of the populations. Epigenetic changes (e.g., weathering – early aging of racialized women) due to DNA methylation of genes among racialized populations are markers of intergenerational trauma due to racial/caste discrimination. Likewise, chronic stresses resulting from intergenerational racial/caste discrimination cause ‘allostatic load,’ characterized by an imbalance of neuronal and hormonal dysfunction, leading to occurrences of chronic diseases (e.g., hypertension, diabetes, mental health) at disproportionate rates among racialized populations. Major areas identified for reparative policy changes and interventions for eliminating health impacts of racism/casteism include health disparity research, organizational structures, programs and processes, racial justice in population health, cultural trauma, equitable healthcare system, and genetic discrimination.
Highlights
Research on the relationship between structural racism and population-level health outcomes and on the health impacts of policy changes and interventions has largely overlooked caste, which is a system of racialization that pre-dates US racial categories.
A cross-disciplinary global ‘caste’ approach is adopted to examine various forms of historical decent-based racial and caste discrimination in three case-study countries.
Major theories and praxis explaining research and experiences of structural racial and caste discrimination impacting health disparities are consolidated to synthesize a unified body of knowledge for the 21st century.
While genetic variations occur naturally, they do not inherently contribute to the social constructs of race or caste.
Reparative policy changes and interventions are necessary to eliminate deeply entrenched structural health disparities rooted in racism and casteism.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The first author DPR is the recipient of Fulbright Visiting Scholar award in the position of 2023 Fulbright Canada Research Chair in Race and Health Policy at the Cecil C. Humphreys School of Law, University of Memphis for conducting this research sponsored by Fulbright Canada. The Law School provided in-house support for hiring BMW as a Research Associate to assist in the activities and contribution to activities of this research. DPR is thankful to the Law School Faculty and Staff for their cooperation and logistic support during his Fulbright visit that made this research possible. DPR also is thankful to Wendy Kebwaro, Senior Executive Director, British Columbia Centre for Disease Control for her support to DPR the Fulbright award
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used information and data results from published peer reviewed journal papers. No IRB requirements are applicable.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
